REFERENCES
- World Health Organization (WHO). Global tuberculosis report. 2018. www.who.int/tb/publications/global_report/en/.
- Abu El-Asrar AM, Abouammoh M, Al-Mezaine HS. Tuberculous uveitis. Int Ophthalmol Clin. 2010;50:19–39. doi:10.1097/IIO.0b013e3181d2ccb9.
- Lee C, Agrawal R, Pavesio C. Ocular tuberculosis – A clinical conundrum. Ocul Immunol Inflamm. 2016;24(2):237–242. doi:10.3109/09273948.2014.985387.
- Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101(1):6–9. doi:10.1136/bjophthalmol-2016-309531.
- Gupta V, Gupta A, Rao NA. Intraocular tuberculosis – an update. Surv Opthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
- Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):7–13. doi:10.3109/09273948.2014.967358.
- Rosenbaum JT. To be or not TB? Br J Ophthalmol. 2014;98(8):999–1000. doi:10.1136/bjophthalmol-2014-304883.
- Kee AR, Gonzalez-Lopez JJ, Al-Hity A, et al. Anti tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol. 2016;61(5):628–653. doi:10.1016/j.survophthal.2016.03.001.
- Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with tubercular uveitis in the Collaborative Ocular Tuberculosis Study. Invest Ophthalmol Vis Sci. 2018;59(10):4162–4171. doi:10.1167/iovs.18-24102.
- Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:10.1001/jamaophthalmol.2017.4485.
- Agarwal A, Agrawal R, Gunasekaran DV, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and management of tubercular uveitis: global trends. Ocul Immunol Inflamm. 2019;27(3):465–473.
- Agarwal R, Gunasekaran DV, Agrawal A, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis. Ocul Immunol Inflamm. 2018;29:1–11. doi:10.1080/09273948.2018.1489061.
- Gunasekeran DV, Agrawal R, Agarwal A, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 251 patients with tubercular retinal vasculitis. Retina. 2019 Aug;39(8):1623–1630.
- Al-Qarni A, Abouammoh MA, Almousa AN, Mousa A, Abu El-Asrar AM. Presumed tuberculous uveitis in a university-based tertiary referral center in Saudi Arabia. Int Ophthalmol. 2019;39(2):317–333. doi:10.1007/s10792-017-0815-9.
- Ang L, Kee A, Yeo TH, et al. Treatment outcome in patients with presumed tubercular uveitis at a tertiary referral eye care centre in Singapore. Int Ophthalmol. 2018;38(1):11–18. doi:10.1007/s10792-016-0401-6.
- Manousaridis K, Ong E, Stenton C, Gupta R, Browning AC, Pandit R. Clinical presentation, treatment, and outcomes in presumed intraocular tuberculosis: experience from Newcastle upon Tyne, UK. Eye (Lond). 2013;27(4):480–486. doi:10.1038/eye.2013.11.
- Ng KK, Nisbet M, Damato EM, Sims JL. Presumed tuberculous uveitis in non-endemic country for tuberculosis: case series from a New Zealand tertiary uveitis clinic. Clin Exp Ophthalmol. 2017;45(4):357–365. doi:10.1111/ceo.12881.
- Vos AG, Wassenberg MWM, de Hoog J, Oosterheert JJ. Diagnosis and treatment of tuberculous uveitis in a low endemic setting. Int J Infect Dis. 2013;17(11):e993–999. doi:10.1016/j.ijid.2013.03.019.
- Khochtali S, Gargouri S, Abroug N, et al. The spectrum of presumed tubercular uveitis in Tunisia, North Africa. Int Ophthalmol. 2015;35(5):663–671. doi:10.1007/s10792-014-9992-y.
- Gupta A, Bansal R, Gupta V, Sharma A, Bambery P. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149(4):562–570. doi:10.1016/j.ajo.2009.11.020.
- Shahidatul-Adha M, Zunaina E, Liza-Sharmini AT, et al. Ocular tuberculosis in Hospital Universiti Sains Malaysia - A case series. Ann Med Surg (Lond). 2017;24:25–30. doi:10.1016/j.amsu.2017.10.003.
- La Distia Nora R, van Velthoven MEJ, Ten Dam-van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157(4):754–761. doi:10.1016/j.ajo.2013.11.013.
- Agrawal R, Gupta B, Gonzalez-Lopez JJ. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):40–46. doi:10.3109/09273948.2014.986584.
- Hayward S, Harding RM, McShane H, Tanner R. Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK. F1000Res. 2018;7:461. doi:10.12688/f1000research.
- Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):14–24. doi:10.3109/09273948.2014.986582.
- Census of Population and Housing: Census Dictionary. cat. no. 2901.0. 2016. www.abs.gov.au/census.